Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 2.4.2.30 - NAD+ ADP-ribosyltransferase and Organism(s) Bos taurus

for references in articles please use BRENDA:EC2.4.2.30
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
     2 Transferases
         2.4 Glycosyltransferases
             2.4.2 Pentosyltransferases
                2.4.2.30 NAD+ ADP-ribosyltransferase
IUBMB Comments
The ADP-D-ribosyl group of NAD+ is transferred to an acceptor carboxy group on a histone or the enzyme itself, and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20--30 units.
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Bos taurus
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Bos taurus
The enzyme appears in selected viruses and cellular organisms
Synonyms
parp, pertussis toxin, parp-1, poly(adp-ribose) polymerase, parp1, poly (adp-ribose) polymerase, poly(adp-ribose) polymerase-1, c3 exoenzyme, adprt, exoenzyme s, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
(adenosine diphosphoribose)transferase, nicotinamide adenine dinucleotide-protein
-
-
-
-
193-kDa vault protein
-
-
-
-
adenosine diphosphate ribosyltransferase
-
-
-
-
ADP-ribosyltransferase
-
-
-
-
ADP-ribosyltransferase (polymerizing)
-
-
-
-
ADPRT
-
-
-
-
C3 exoenzyme
-
-
-
-
exoenzyme C3
-
-
-
-
exoenzyme S
-
-
-
-
msPARP
-
-
-
-
NAD(+) ADP-ribosyltransferase
-
-
-
-
NAD+:ADP-ribosyltransferase (polymerizing)
-
-
-
-
NAD-protein ADP-ribosyltransferase
-
-
-
-
pADPRT
-
-
-
-
PARP
-
-
-
-
PARP-1
-
-
PARP-related/IalphaI-related H5/proline-rich
-
-
-
-
PH5P
-
-
-
-
poly(ADP-ribose) polymerase
-
-
-
-
poly(ADP-ribose) polymerase-1
-
-
poly(ADP-ribose) synthase
-
-
-
-
poly(ADP-ribose) transferase
-
-
-
-
poly(ADP-ribosyl)transferase
-
-
-
-
poly[ADP-ribose] synthetase
-
-
-
-
TANK1
-
-
-
-
TANK2
-
-
-
-
Tankyrase-like protein
-
-
-
-
Tankyrase-related protein
-
-
-
-
TRF1-interacting ankyrin-related ADP-ribose polymerase
-
-
-
-
VPARP
-
-
-
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
pentosyl group transfer
-
-
-
-
PATHWAY SOURCE
PATHWAYS
SYSTEMATIC NAME
IUBMB Comments
NAD+:poly(ADP-D-ribosyl)-acceptor ADP-D-ribosyl-transferase
The ADP-D-ribosyl group of NAD+ is transferred to an acceptor carboxy group on a histone or the enzyme itself, and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20--30 units.
CAS REGISTRY NUMBER
COMMENTARY hide
58319-92-9
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
show the reaction diagram
NAD+ + histone H2B
nicotinamide + (ADP-D-ribosyl)-histone H2B
show the reaction diagram
-
-
-
-
?
additional information
?
-
-
cuts produced in vivo on DNA during DNA repair activate the enzyme, which then synthesiszes poly(ADP-ribose) on histone H1, in particular, and contributes to the opening of the 25 nm chromatin fiber, resulting in the increased accessibility of DNA to excision repair enzymes
-
-
?
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
show the reaction diagram
-
the enzyme is a DNA repair enzyme
-
-
?
additional information
?
-
-
cuts produced in vivo on DNA during DNA repair activate the enzyme, which then synthesiszes poly(ADP-ribose) on histone H1, in particular, and contributes to the opening of the 25 nm chromatin fiber, resulting in the increased accessibility of DNA to excision repair enzymes
-
-
?
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1(2H)-phthalazinone
-
IC50: 0.012 mM
1,2-benzopyrone
-
IC50: 2.8 mM
1,3-benzodiazine
-
IC50: 2.0 mM
1,3-dihydroxynaphthalene
-
IC50: 1.3 mM
1,4-benzoquinone
-
IC50: 0.4 mM
1,4-naphthalenedione
-
IC50: 0.25 mM
1,5-dihydroxyisoquinoline
-
IC50: 0.00039 mM
1,8-naphthalimide
-
IC50: 0.0014 mM
1-hydroxy-2-methyl-4-aminonaphthalene
-
IC50: 1.3 mM
1-hydroxyisoquinoline
-
IC50: 0.007 mM
1-Indanone
-
IC50: 0.81 mM
1-methylnicotinamide chloride
2,3-benzodiazine
-
IC50: 0.15 mM
2,3-dichloro-1,4-naphthoquinone
-
IC50: 0.26 mM
2,3-dihydro-1,4-phthalazinedione
-
IC50: 0.03 mM
2,4(1H,3H)-quinazolinedione
-
IC50: 0.0081 mM
2,6-difluorobenzamide
-
IC50: 0.18 mM
2-acetamidobenzamide
-
IC50: 1.0 mM
2-amino-3-chloro-1,4-naphthoquinone
-
IC50: 0.82 mM
2-Aminobenzamide
2-bromobenzamide
-
IC50: 2.9 mM
2-chlorobenzamide
-
IC50: 1.0 mM
2-fluorobenzamide
-
IC50: 0.12 mM
2-Hydroxy-1,4-naphthoquinone
-
IC50: 0.33 mM
2-hydroxybenzamide
-
IC50: 0.82 mM
2-mercapto-4(3H)-quinazolinone
-
IC50: 0.044 mM
2-Methoxybenzamide
-
IC50: 0.2 mM
2-methyl-1,4-benzopyrone
-
IC50: 0.045 mM
2-methyl-1,4-naphthoquinone
-
IC50: 0.42 mM
2-methyl-3-phytyl-1,4-naphthoquinone
-
IC50: 0.52 mM
2-methyl-4(3H)-quinazolinone
-
IC50: 0.056 mM
2-methylbenzamide
-
IC50: 1.5 mM
2-methylchromone
-
IC50: 0.045 mM
2-nitro-6(5H)-phenanthridione
-
IC50: 0.00035 mM
2-phenylchromone
-
IC50: 0.022 mM
2-trichloromethyl-4(3H)-quinazolinone
-
IC50: 2.2 mM
2H-benz[c]isoquinolin-1-one
-
IC50: 0.0003 mM
2H-benz[de]isoquinoline-1,3-dione
-
IC50: 0.0014 mM
3,4-dihydro-1(2H)-naphthalenone
-
IC50: 0.31 mM
3,5-dibromosalicylamide
-
IC50: 0.56 mM
3,5-dimethoxybenzamide
-
IC50: 1.2 mM
3,5-dinitrobenzamide
-
IC50: 2.5 mM
3-(N,N-dimethylamino)benzamide
-
IC50: 0.12 mM
3-Acetamidobenzamide
-
IC50: 0.012 mM
3-acetamidosalicylamide
-
IC50: 2.0 mM
3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole
-
i.e. Trp-P-1, 94% inhibition at 5 mM, IC50: 0.22 mM
3-amino-1-methyl-5H-pyrido[4,3-b]indole
-
i.e. Trp-P-2, 34% activation at 1 mM, 7% inhibition at 5 mM, IC50: 2.2 mM
3-aminobenzamide
3-Aminophthalhydrazide
-
IC50: 0.023 mM
3-bromobenzamide
-
IC50: 0.055 mM
3-Chlorobenzamide
-
IC50: 0.22 mM
3-Fluorobenzamide
-
IC50: 0.2 mM
3-Hydroxybenzamide
-
IC50: 0.0091 mM
3-isobutyl-1-methylxanthine
-
IC50: 3.1 mM
3-Methoxybenzamide
3-Methylbenzamide
-
IC50: 0.19 mM
3-nitrobenzamide
-
IC50: 0.16 mM
3-nitrophthalhydrazide
-
IC50: 0.072 mM
3-nitrosalicylamide
-
IC50: 1.6 mM
4,8-dihydroxy-2-quinolinecarboxylic acid
-
IC50: 0.19 mM
4-amino-1,8-naphthalimide
-
IC50: 0.00018 mM
4-Aminobenzamide
4-aminophthalhydrazide
-
IC50: 0.29 mM
4-bromobenzamide
-
IC50: 2.2 mM
4-chlorobenzamide
-
IC50: 0.3 mM
4-chromanone
-
IC50: 0.72 mM
4-fluorobenzamide
-
IC50: 0.2 mM
4-hydroxy-2-methylquinoline
-
IC50: 0.074 mM
4-hydroxy-2-quinolinecarboxylic acid
-
IC50: 0.67 mM
4-hydroxybenzamide
-
IC50: 0.28 mM
4-Hydroxycoumarin
-
IC50: 0.57 mM
4-hydroxypyridine
-
IC50: 2.3 mM
4-hydroxyquinazoline
-
IC50: 0.0095 mM
4-hydroxyquinoline
-
IC50: 0.08 mM
4-methoxybenzamide
-
IC50: 1.1 mM
4-methylbenzamide
-
IC50: 1.8 mM
4-nitrophthalhydrazide
-
IC50: 0.51 mM
4-[[[6-cyano-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4,6,7-hexahydroquinolin-3-yl](pyridin-2-ylsulfonyl)amino]methyl]-N,N-dimethylpiperidine-1-carboxamide
-
activates in presence of Mg2+, inhibits in absence of Mg2+
5-acetamidosalicylamide
-
IC50: 0.045 mM
5-aminosalicylamide
-
IC50: 0.1 mM
5-bromodeoxyuridine
-
IC50: 0.015 mM
5-Bromouracil
-
IC50: 0.16 mM
5-Bromouridine
-
IC50: 0.21 mM
5-chlorosalicylamide
-
IC50: 0.19 mM
5-Chlorouracil
-
IC50: 0.27 mM
5-hydroxy-1,4-naphthoquinone
-
IC50: 0.25 mM
5-Hydroxy-2-methyl-1,4-naphthoquinone
-
IC50: 0.7 mM
5-Iodouracil
-
IC50: 0.071 mM
5-iodouridine
-
IC50: 0.043 mM
5-Methylnicotinamide
5-methyluracil
-
IC50: 0.29 mM
5-Nitrouracil
-
IC50: 0.43 mM
6(5H)-phenanthridinone
-
IC50: 0.0003 mM
6-aminocoumarin
-
IC50: 0.85 mM
6-aminonicotinamide
-
IC50: 1.1 mM
8-acetamidocarsalam
-
IC50: 1.4 mM
8-Methylnicotinamide
-
IC50: 7.8 mM
acetophenone
-
IC50: 2.3 mM
all-trans-retinal
-
IC50: 0.45 mM
alpha-picolinamide
-
IC50: 0.25 mM
arachidonic acid
-
-
Benzamide
benzoyleneurea
-
IC50: 0.0081 mM
Caffeine
-
IC50: 1.4 mM
carbonylsalicylamide
-
IC50: 0.46 mM
carsalam
-
5 mM, 88% inhibition in presence of Mg2+, 68% inhibition in absence of Mg2+
Chlorthenoxazin
-
IC50: 0.0085 mM
chromone-2-carboxylic acid
-
IC50: 0.56 mM
cyclohexanecarboxamide
-
IC50: 0.62 mM
EDTA
-
5 mM, 41% inhibition in presence of Mg2+, 2% inhibition in absence of Mg2+
flavone
-
IC50: 0.022 mM
gamma-linolenic acid
-
IC50: 0.12 mM
hypoxanthine
-
IC50: 1.7 mM
Isonicotinamide
-
IC50: 0.99 mM
Isonicotinate hydrazide
-
IC50: 4.8 MM
Isoquinoline
-
5 mM, 47% inhibition in presence of Mg2+, 34% inhibition in absence of Mg2+
linoleic acid
-
IC50: 0.048 mM
linolenic acid
-
IC50: 0.11 mM
m-acetamidoacetophenone
-
IC50: 0.93 mM
m-aminoacetophenone
-
IC50: 1.9 mM
m-hydroxyacetophenone
-
IC50: 0.6 mM
m-phthalamide
-
IC50: 0.05 mM
menadione sodium bisulfite
-
IC50: 0.72 mM
N-(2-chloroethyl)1,8-naphthalamide
-
IC50: above 1.8 mM
N-hydroxynaphthalimide sodium salt
-
IC50: 0.45 mM
nicotinamide
norharman
-
IC50: 4.7 mM
novobiocin
-
IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+
oleic acid
-
IC50: 0.082 mM
palmitoleic acid
-
IC50: 0.095 mM
phthalamide
-
IC50: 1.0 mM
Phthalazine
-
5 mM, 91% inhibition in presence of Mg2+, 79% inhibition in absence of Mg2+
Pyrazinamide
-
IC50: 0.13 mM
Quinazoline
-
5 mM, 63% inhibition in presence of Mg2+, 50% inhibition in absence of Mg2+
reserpine
-
IC50: 0.79 mM
Theobromine
-
IC50: 0.11 mM
theophylline
-
IC50: 0.0046
thiobenzamide
-
IC50: 0.62 mM
Thionicotinamide
-
IC50: 1.8 mM
thymidine
trans-decahydro-1-naphthalenone
-
IC50: 4.3 mM
vitamin K1
-
IC50: 0.0019 mM
vitamin K3
-
IC50: 0.42 mM
xanthurenic acid
-
5 mM, 88% inhibition in presence of Mg2+, 65% inhibition in absence of Mg2+
Zn2+
-
ZnCl2, IC50: 0.077 mM
additional information
-
comparison of the effects of heterocyclic amines acting as potent carcinogens on PARP-1 and the arginine-specific mono-ADP-ribosyltransferase A, MART-A, EC 2.4.2.31, overview
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
3-amino-1-methyl-5H-pyrido[4,3-b]indole
-
i.e. Trp-P-2, 34% activation at 1 mM, 7% inhibition at 5 mM, IC50: 2.2 mM
4-[[[6-cyano-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4,6,7-hexahydroquinolin-3-yl](pyridin-2-ylsulfonyl)amino]methyl]-N,N-dimethylpiperidine-1-carboxamide
-
activates in presence of Mg2+, inhibits in absence of Mg2+
DNA
-
the enzyme is completely dependent on the presence of DNA containing single or double stranded breaks. Activation results in a decondensation of chromatin superstructure in vitro, which is caused mainly by hyper(ADP-ribosyl)ation of histone H1
harmaline hydrochloride
-
activates more strongly in absence of Mg2+ than in presence of Mg2+
Phthalic acid
-
activates more strongly in absence of Mg2+ than in presence of Mg2+
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.012
1(2H)-phthalazinone
Bos taurus
-
IC50: 0.012 mM
2.8
1,2-benzopyrone
Bos taurus
-
IC50: 2.8 mM
2
1,3-benzodiazine
Bos taurus
-
IC50: 2.0 mM
1.3
1,3-dihydroxynaphthalene
Bos taurus
-
IC50: 1.3 mM
0.4
1,4-benzoquinone
Bos taurus
-
IC50: 0.4 mM
0.25
1,4-naphthalenedione
Bos taurus
-
IC50: 0.25 mM
0.00039
1,5-dihydroxyisoquinoline
Bos taurus
-
IC50: 0.00039 mM
0.0014
1,8-naphthalimide
Bos taurus
-
IC50: 0.0014 mM
1.3
1-hydroxy-2-methyl-4-aminonaphthalene
Bos taurus
-
IC50: 1.3 mM
0.007
1-hydroxyisoquinoline
Bos taurus
-
IC50: 0.007 mM
0.81
1-Indanone
Bos taurus
-
IC50: 0.81 mM
1.7 - 3.8
1-methylnicotinamide chloride
0.15
2,3-benzodiazine
Bos taurus
-
IC50: 0.15 mM
0.26
2,3-dichloro-1,4-naphthoquinone
Bos taurus
-
IC50: 0.26 mM
0.03
2,3-dihydro-1,4-phthalazinedione
Bos taurus
-
IC50: 0.03 mM
0.0081
2,4(1H,3H)-quinazolinedione
Bos taurus
-
IC50: 0.0081 mM
0.18
2,6-difluorobenzamide
Bos taurus
-
IC50: 0.18 mM
1
2-acetamidobenzamide
Bos taurus
-
IC50: 1.0 mM
0.82
2-amino-3-chloro-1,4-naphthoquinone
Bos taurus
-
IC50: 0.82 mM
0.1 - 0.65
2-Aminobenzamide
2.9
2-bromobenzamide
Bos taurus
-
IC50: 2.9 mM
1
2-chlorobenzamide
Bos taurus
-
IC50: 1.0 mM
0.12
2-fluorobenzamide
Bos taurus
-
IC50: 0.12 mM
0.33
2-Hydroxy-1,4-naphthoquinone
Bos taurus
-
IC50: 0.33 mM
0.82
2-hydroxybenzamide
Bos taurus
-
IC50: 0.82 mM
0.044
2-mercapto-4(3H)-quinazolinone
Bos taurus
-
IC50: 0.044 mM
0.2
2-Methoxybenzamide
Bos taurus
-
IC50: 0.2 mM
0.045
2-methyl-1,4-benzopyrone
Bos taurus
-
IC50: 0.045 mM
0.42
2-methyl-1,4-naphthoquinone
Bos taurus
-
IC50: 0.42 mM
0.52
2-methyl-3-phytyl-1,4-naphthoquinone
Bos taurus
-
IC50: 0.52 mM
0.056
2-methyl-4(3H)-quinazolinone
Bos taurus
-
IC50: 0.056 mM
1.5
2-methylbenzamide
Bos taurus
-
IC50: 1.5 mM
0.045
2-methylchromone
Bos taurus
-
IC50: 0.045 mM
0.00035
2-nitro-6(5H)-phenanthridione
Bos taurus
-
IC50: 0.00035 mM
0.022
2-phenylchromone
Bos taurus
-
IC50: 0.022 mM
2.2
2-trichloromethyl-4(3H)-quinazolinone
Bos taurus
-
IC50: 2.2 mM
0.0003
2H-benz[c]isoquinolin-1-one
Bos taurus
-
IC50: 0.0003 mM
0.0014
2H-benz[de]isoquinoline-1,3-dione
Bos taurus
-
IC50: 0.0014 mM
0.31
3,4-dihydro-1(2H)-naphthalenone
Bos taurus
-
IC50: 0.31 mM
0.56
3,5-dibromosalicylamide
Bos taurus
-
IC50: 0.56 mM
1.2
3,5-dimethoxybenzamide
Bos taurus
-
IC50: 1.2 mM
2.5
3,5-dinitrobenzamide
Bos taurus
-
IC50: 2.5 mM
0.12
3-(N,N-dimethylamino)benzamide
Bos taurus
-
IC50: 0.12 mM
0.012
3-Acetamidobenzamide
Bos taurus
-
IC50: 0.012 mM
2
3-acetamidosalicylamide
Bos taurus
-
IC50: 2.0 mM
0.22
3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole
Bos taurus
-
i.e. Trp-P-1, 94% inhibition at 5 mM, IC50: 0.22 mM
2.2
3-amino-1-methyl-5H-pyrido[4,3-b]indole
Bos taurus
-
i.e. Trp-P-2, 34% activation at 1 mM, 7% inhibition at 5 mM, IC50: 2.2 mM
0.0054 - 0.33
3-aminobenzamide
0.023
3-Aminophthalhydrazide
Bos taurus
-
IC50: 0.023 mM
0.055
3-bromobenzamide
Bos taurus
-
IC50: 0.055 mM
0.22
3-Chlorobenzamide
Bos taurus
-
IC50: 0.22 mM
0.2
3-Fluorobenzamide
Bos taurus
-
IC50: 0.2 mM
0.0091
3-Hydroxybenzamide
Bos taurus
-
IC50: 0.0091 mM
3.1
3-isobutyl-1-methylxanthine
Bos taurus
-
IC50: 3.1 mM
0.0034 - 0.017
3-Methoxybenzamide
0.19
3-Methylbenzamide
Bos taurus
-
IC50: 0.19 mM
0.16
3-nitrobenzamide
Bos taurus
-
IC50: 0.16 mM
0.072
3-nitrophthalhydrazide
Bos taurus
-
IC50: 0.072 mM
1.6
3-nitrosalicylamide
Bos taurus
-
IC50: 1.6 mM
0.19
4,8-dihydroxy-2-quinolinecarboxylic acid
Bos taurus
-
IC50: 0.19 mM
0.00018
4-amino-1,8-naphthalimide
Bos taurus
-
IC50: 0.00018 mM
0.4 - 1.8
4-Aminobenzamide
0.29
4-aminophthalhydrazide
Bos taurus
-
IC50: 0.29 mM
2.2
4-bromobenzamide
Bos taurus
-
IC50: 2.2 mM
0.3
4-chlorobenzamide
Bos taurus
-
IC50: 0.3 mM
0.72
4-chromanone
Bos taurus
-
IC50: 0.72 mM
0.2
4-fluorobenzamide
Bos taurus
-
IC50: 0.2 mM
0.074
4-hydroxy-2-methylquinoline
Bos taurus
-
IC50: 0.074 mM
0.67
4-hydroxy-2-quinolinecarboxylic acid
Bos taurus
-
IC50: 0.67 mM
0.28
4-hydroxybenzamide
Bos taurus
-
IC50: 0.28 mM
0.57
4-Hydroxycoumarin
Bos taurus
-
IC50: 0.57 mM
2.3
4-hydroxypyridine
Bos taurus
-
IC50: 2.3 mM
0.0095
4-hydroxyquinazoline
Bos taurus
-
IC50: 0.0095 mM
0.08
4-hydroxyquinoline
Bos taurus
-
IC50: 0.08 mM
1.1
4-methoxybenzamide
Bos taurus
-
IC50: 1.1 mM
1.8
4-methylbenzamide
Bos taurus
-
IC50: 1.8 mM
0.51
4-nitrophthalhydrazide
Bos taurus
-
IC50: 0.51 mM
0.045
5-acetamidosalicylamide
Bos taurus
-
IC50: 0.045 mM
0.1
5-aminosalicylamide
Bos taurus
-
IC50: 0.1 mM
0.015
5-bromodeoxyuridine
Bos taurus
-
IC50: 0.015 mM
0.16
5-Bromouracil
Bos taurus
-
IC50: 0.16 mM
0.21
5-Bromouridine
Bos taurus
-
IC50: 0.21 mM
0.19
5-chlorosalicylamide
Bos taurus
-
IC50: 0.19 mM
0.27
5-Chlorouracil
Bos taurus
-
IC50: 0.27 mM
0.25
5-hydroxy-1,4-naphthoquinone
Bos taurus
-
IC50: 0.25 mM
0.7
5-Hydroxy-2-methyl-1,4-naphthoquinone
Bos taurus
-
IC50: 0.7 mM
0.071
5-Iodouracil
Bos taurus
-
IC50: 0.071 mM
0.043
5-iodouridine
Bos taurus
-
IC50: 0.043 mM
0.07 - 0.35
5-Methylnicotinamide
0.29
5-methyluracil
Bos taurus
-
IC50: 0.29 mM
0.43
5-Nitrouracil
Bos taurus
-
IC50: 0.43 mM
0.0003
6(5H)-phenanthridinone
Bos taurus
-
IC50: 0.0003 mM
0.85
6-aminocoumarin
Bos taurus
-
IC50: 0.85 mM
1.1
6-aminonicotinamide
Bos taurus
-
IC50: 1.1 mM
1.4
8-acetamidocarsalam
Bos taurus
-
IC50: 1.4 mM
7.8
8-Methylnicotinamide
Bos taurus
-
IC50: 7.8 mM
2.3
acetophenone
Bos taurus
-
IC50: 2.3 mM
0.45
all-trans-retinal
Bos taurus
-
IC50: 0.45 mM
0.25
alpha-picolinamide
Bos taurus
-
IC50: 0.25 mM
0.0033 - 0.22
Benzamide
0.0081
benzoyleneurea
Bos taurus
-
IC50: 0.0081 mM
1.4
Caffeine
Bos taurus
-
IC50: 1.4 mM
0.46
carbonylsalicylamide
Bos taurus
-
IC50: 0.46 mM
0.0085
Chlorthenoxazin
Bos taurus
-
IC50: 0.0085 mM
0.56
chromone-2-carboxylic acid
Bos taurus
-
IC50: 0.56 mM
0.62
cyclohexanecarboxamide
Bos taurus
-
IC50: 0.62 mM
0.022
flavone
Bos taurus
-
IC50: 0.022 mM
0.12
gamma-linolenic acid
Bos taurus
-
IC50: 0.12 mM
1.7
hypoxanthine
Bos taurus
-
IC50: 1.7 mM
0.99
Isonicotinamide
Bos taurus
-
IC50: 0.99 mM
4.8
Isonicotinate hydrazide
Bos taurus
-
IC50: 4.8 mM
0.048
linoleic acid
Bos taurus
-
IC50: 0.048 mM
0.11
linolenic acid
Bos taurus
-
IC50: 0.11 mM
0.93
m-acetamidoacetophenone
Bos taurus
-
IC50: 0.93 mM
1.9
m-aminoacetophenone
Bos taurus
-
IC50: 1.9 mM
0.6
m-hydroxyacetophenone
Bos taurus
-
IC50: 0.6 mM
0.05
m-phthalamide
Bos taurus
-
IC50: 0.05 mM
0.72
menadione sodium bisulfite
Bos taurus
-
IC50: 0.72 mM
1.8
N-(2-chloroethyl)1,8-naphthalamide
Bos taurus
-
IC50: above 1.8 mM
0.45
N-hydroxynaphthalimide sodium salt
Bos taurus
-
IC50: 0.45 mM
0.031 - 0.21
nicotinamide
4.7
norharman
Bos taurus
-
IC50: 4.7 mM
2.2
novobiocin
Bos taurus
-
IC50: 2.2 mM, 5 mM, 90% inhibition in presence of Mg2+, 59% inhibition in absence of Mg2+
0.082
oleic acid
Bos taurus
-
IC50: 0.082 mM
0.095
palmitoleic acid
Bos taurus
-
IC50: 0.095 mM
1
phthalamide
Bos taurus
-
IC50: 1.0 mM
0.13
Pyrazinamide
Bos taurus
-
IC50: 0.13 mM
0.79
reserpine
Bos taurus
-
IC50: 0.79 mM
0.11
Theobromine
Bos taurus
-
IC50: 0.11 mM
0.046
theophylline
Bos taurus
-
IC50: 0.046 mM
0.62
thiobenzamide
Bos taurus
-
IC50: 0.62 mM
1.8
Thionicotinamide
Bos taurus
-
IC50: 1.8 mM
0.043 - 0.18
thymidine
4.3
trans-decahydro-1-naphthalenone
Bos taurus
-
IC50: 4.3 mM
0.0019
vitamin K1
Bos taurus
-
IC50: 0.0019 mM
0.42
vitamin K3
Bos taurus
-
IC50: 0.42 mM
0.077
Zn2+
Bos taurus
-
ZnCl2, IC50: 0.077 mM
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
8
-
assay at
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
37
-
assay at
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
PARP1_BOVIN
1016
0
113486
Swiss-Prot
other Location (Reliability: 2)
F1MU08_BOVIN
1016
0
113368
TrEMBL
other Location (Reliability: 1)
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Banasik, M.; Komura, H.; Shimoyama, M.; Ueda, K.
Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase
J. Biol. Chem.
267
1569-1575
1992
Bos taurus
Manually annotated by BRENDA team
De Murcia, G.; Huletsky, A.; Poirier, G.G.
Modulation of chromatin structure by poly(ADP-ribosyl)ation
Biochem. Cell Biol.
66
626-635
1988
Bos taurus
Manually annotated by BRENDA team
Rankin, P.W.; Jacobson, E.L.; benjamin, R.C.; Moss, J.; Jacobson, M.K.
Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo
J. Biol. Chem.
264
4312-4317
1989
Bos taurus
Manually annotated by BRENDA team
Banasik, M.; Stedeford, T.; Strosznajder, R.P.; Hsu, C.H.; Tanaka, S.; Ueda, K.
Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A
J. Physiol. Pharmacol.
57 Suppl 4
15-22
2006
Bos taurus
Manually annotated by BRENDA team